🔎 Trials Near Me

Home › Mga Sakit sa Baga › Pennsylvania

Pag-aaral pangklinika para sa Mga Sakit sa Baga sa Pennsylvania

21 pag-aaral para sa Mga Sakit sa Baga ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Clinical Research Associates of Central PA, LLC, DuBois
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06977581

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Clinical Research Associates of Central PA, DuBois
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07759245

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  • University of Pittsburgh Medical Centre, Pittsburgh
Nagre-recruitPhase 3
28 Days · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT02735707

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Alliance Cancer Specialists, PC, Horsham
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06119581

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05624450

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Clinical Research Associates of Central PA, DuBois
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07284602

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Preferred Primary Care Physicians, Uniontown
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • TRC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • UPMC Division of Infectious Disease Clinic, Pittsburgh
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07013474

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Alliance Cancer Specialists, Sellersville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06765109

A Study of COVID-19 Vaccine(s) in Children and Adults

  • DM Clinical Research, Philadelphia
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07798648

American Lung Association (ALA) Lung Health Cohort

  • Temple University, Philadelphia
  • University of Pittsburg-Emphysema/COPD Research Center, Pittsburgh
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 hanggang 35 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Temple University, Philadelphia
  • University of Pittsburgh, Pittsburgh
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091

Deep Functional Phenotyping of the ALA Lung Health Cohort

  • University of Pittsburgh - Emphysema/COPD Research Center, Pittsburgh
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 hanggang 35 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Allegheny General Hospital, Natrona Heights
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05361174

Data Collection Using Eko Digital Devices in a Clinical Setting

  • Jefferson Einstein Philadelphia Hospital, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 26, 2026 · NCT07227376

Supporting Evidence-based Responses to Emotional Needs in Emphysema

  • University of Pennsylvania, Philadelphia
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT06600126

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Temple University Hospital-Temple Lung Center, Philadelphia
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT05975983

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.